Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
/	O
IV	O
Dye,	O
Iodine	O
Containing	O
Contrast	O
Media	O
/	O
lactose	O
Attending:	O
___.	O
Chief	O
Complaint:	O
nausea,	O
vomiting	O
and	O
diarrhea	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
with	O
history	O
of	O
DM2,	O
HTN,	O
Grave's	O
disease,	O
anemia	O
who	O
presents	O
with	O
nausea,	O
vomiting	O
and	O
diarrhea	O
since	O
___	O
who	O
presents	O
with	O
acute	O
worsening	O
of	O
nausea,	O
vomiting	O
and	O
diarrhea	O
with	O
dehydration	O
over	O
last	O
3	O
days.	O
Per	O
her	O
report,	O
she	O
was	O
relatively	O
normal	O
until	O
___.	O
At	O
that	O
time	O
she	O
developed	O
intermittent	O
but	O
significant	O
nausea,	O
vomiting	O
and	O
diarreha.	O
She	O
feels	O
as	O
though	O
food	O
gets	O
stuck	O
in	O
her	O
throat.	O
Also,	O
she	O
notes	O
a	O
lack	O
of	O
taste	O
for	O
food.	O
She	O
has	O
not	O
been	O
eating	O
or	O
drinking	O
much	O
because	O
of	O
lack	O
of	O
desire	O
and	O
nausea	O
and	O
vomiting.	O
Her	O
diarrhea,	O
per	O
report,	O
is	O
partially	O
formed	O
and	O
partially	O
loose.	O
Multiple	O
times	O
per	O
day	O
and	O
sometimes	O
dark.	O
She	O
was	O
evaluated	O
by	O
GI	O
and	O
had	O
EGD,	O
colonoscopy	O
and	O
MRE	O
with	O
evidence	O
of	O
some	O
inflammation	O
on	O
biopsies,	O
but	O
no	O
clear	O
diagnosis.	O
She	O
notes	O
that	O
over	O
the	O
last	O
___	O
days	O
her	O
symptoms	O
have	O
worsened	O
with	O
nausea	O
and	O
vomiting	O
limiting	O
her	O
PO	O
intake.	O
She	O
feels	O
dehydrated	O
and	O
lightheaded	O
upon	O
standing.	O
Her	O
diarrhea	O
has	O
been	O
controlled	O
by	O
immodium.	O
She	O
presented	O
to	O
___	O
EW	O
and	O
was	O
given	O
3L	O
IVF	O
and	O
admitted	O
for	O
further	O
work	O
up	O
and	O
evaluation.	O
Currently,	O
she	O
feels	O
somewhat	O
improved	O
but	O
notes	O
a	O
new	O
back	O
discomfort	O
on	O
her	O
right	O
flank.	O
No	O
urinary	O
symptoms.	O
ROS:	O
She	O
notes	O
recent	O
surgery,	O
nausea,	O
vomiting,	O
loss	O
of	O
taste,	O
weight	B-Weight_loss
loss,	B-Weight_loss
anorexia,	O
epigastric	O
discomfort,	O
globus,	O
dark	B-Upper_gastrointestinal_haemorrhage
stools,	B-Upper_gastrointestinal_haemorrhage
diarrhea.	O
She	O
denies	O
fevers,	O
chills,	O
chest	O
pain,	O
shortness	O
of	O
breath,	O
blood	B-Upper_gastrointestinal_haemorrhage
in	B-Upper_gastrointestinal_haemorrhage
emesis,	B-Upper_gastrointestinal_haemorrhage
pancreatitis,	O
travel	O
history,	O
fatty	O
stools,	O
dysuria,	O
frequency,	O
neurologic	O
symptoms	O
or	O
psychiatric	O
symptoms.	O
Other	O
ROS	O
were	O
negative.	O
No	O
changes	O
in	O
medications.	O
Past	O
Medical	O
History:	O
Hypertension	O
Diabetes	O
mellitus,	O
type	O
2	O
Obesity	O
Hyperlipidemia	O
Sialadenitis	O
Grave's	O
disease	O
Anxiety	O
Carpal	O
tunnel	O
syndrome	O
Anemia	O
NOS	O
Lateral	O
epicondylitis	O
Left	O
renal	O
cell	O
carcinoma	O
treated	O
with	O
RFA	O
ablation	O
___	O
Adnexal	O
cysts	O
s/p	O
removal	O
2	O
weeks	O
ago	O
Social	O
History:	O
___	O
Family	O
History:	O
Grandfather	O
with	O
diabetes.	O
Brother	O
died	O
of	O
renal	O
cancer	O
at	O
___	O
years	O
old.	O
Sister	O
with	O
breast	O
cancer.	O
Physical	O
Exam:	O
Admission	O
exam:	O
General:	O
well	O
appearing,	O
obese	O
female,	O
no	O
apparent	O
distress	O
Vitals:	O
97.7,	O
121/68,	O
56,	O
16,	O
100%	O
RA,	O
___	O
right	O
flank	O
pain	O
HEENT:	O
dry	O
MM,	O
no	O
lesions	O
Neck:	O
no	O
LAD,	O
low	O
JVD	O
Card:	O
RR,	O
nl	O
rate	O
-	O
slighly	O
bradycardic,	O
___	O
systolic	O
murmur,	O
no	O
rubs	O
or	O
gallops	O
Chest:	O
CTAB,	O
no	O
crackles	O
or	O
wheeze	O
Abd:	O
soft,	O
obese,	O
nontender,	O
nondistended,	O
+BS,	O
no	O
masses	O
appreciated,	O
no	O
rigidity,	O
rebound	O
or	O
guarding,	O
no	O
CVA	O
tenderness,	O
mild	O
tenderness	O
over	O
right	O
flank	O
(near	O
inferior	O
costal	O
margin)	O
Ext:	O
wwp,	O
nonpitting	O
edema	O
Skin:	O
no	O
lesions	O
Pulses:	O
2+	O
dp	O
bilat,	O
2+	O
radial	O
Neuro:	O
CN2-12	O
grossly	O
intact	O
Psych:	O
Appropriate	O
Pertinent	O
Results:	O
___	O
02:45AM	O
BLOOD	O
WBC-8.3#	O
RBC-4.23	O
Hgb-11.1*	O
Hct-34.0*	O
MCV-80*	O
MCH-26.3*	O
MCHC-32.7	O
RDW-16.3*	O
Plt	O
___	O
___	O
02:45AM	O
BLOOD	O
Neuts-75.1*	O
Lymphs-17.0*	O
Monos-4.6	O
Eos-2.6	O
Baso-0.7	O
___	O
02:45AM	O
BLOOD	O
Glucose-75	O
UreaN-24*	O
Creat-1.9*	O
Na-138	O
K-4.2	O
Cl-102	O
HCO3-21*	O
AnGap-19	O
___	O
02:45AM	O
BLOOD	O
Calcium-8.9	O
Phos-4.5	O
Mg-1.9	O
___	O
05:24AM	O
BLOOD	O
Lactate-1.1	O
___	O
04:20AM	O
URINE	O
Blood-NEG	O
Nitrite-NEG	O
Protein-NEG	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-5.0	O
Leuks-TR	O
___	O
04:20AM	O
URINE	O
RBC-<1	O
WBC-1	O
Bacteri-FEW	O
Yeast-NONE	O
Epi-<1	O
CXR:	O
prelim	O
read:	O
The	O
lungs	O
are	O
clear.	O
No	O
consolidation	O
is	O
identified	O
to	O
suggest	O
aspiration.	O
There	O
is	O
no	O
pulmonary	O
edema	O
or	O
pleural	O
effusions.	O
Cardiomediastinal	O
and	O
hilar	O
contours	O
are	O
within	O
normal	O
limits.	O
Mild	O
eventration	O
of	O
the	O
right	O
hemidiaphragm	O
is	O
unchanged	O
from	O
prior.	O
Mild	O
elevation	O
of	O
the	O
left	O
hemidiaphragm	O
is	O
also	O
stable.	O
IMPRESSION:	O
No	O
acute	O
cardiopulmonary	O
process.	O
No	O
aspiration.	O
EGD	O
___:	O
Normal	O
mucosa	O
in	O
the	O
esophagus.	O
Mild	O
erythema	O
in	O
the	O
antrum	O
compatible	O
with	O
mild	O
gastritis	O
(biopsy).	O
Normal	O
mucosa	O
in	O
the	O
duodenum	O
(biopsy).	O
Otherwise	O
normal	O
EGD	O
to	O
third	O
part	O
of	O
the	O
duodenum.	O
Colonoscopy	O
___:	O
Mild	O
erythema	O
in	O
the	O
descending	O
and	O
ascending	O
colon	O
compatible	O
with	O
nonspecific	O
erythema	O
(biopsy).	O
Normal	O
mucosa	O
in	O
the	O
colon.	O
Internal	O
hemorrhoids.	O
Otherwise	O
normal	O
colonoscopy	O
to	O
cecum.	O
Gastric	O
biopsies	O
___:	O
Chronic	O
active	O
gastritis	O
with	O
focal	O
intestinal	O
metaplasia	O
and	O
foci	O
suggestive	O
of	O
poorly	O
formed	O
granuloma.	O
Immunohistochemical	O
stain	O
for	O
Helicobacter	O
is	O
negative	O
with	O
adequate	O
controls.	O
GMS	O
stain	O
is	O
negative	O
for	O
fungal	O
organisms.	O
Stain	O
for	O
AFB	O
is	O
negative	O
with	O
adequate	O
controls.	O
B.	O
Duodenal	O
biopsies:	O
Well	O
formed	O
villi	O
are	O
present	O
focally.	O
There	O
is	O
a	O
focal	O
mild	O
increase	O
in	O
intraepithelial	O
lymphocytes	O
and	O
neutrophils	O
in	O
the	O
epithelium.	O
The	O
findings	O
are	O
not	O
specific.	O
C.	O
Random	O
colon	O
biopsies:	O
Very	O
focal	O
active	O
cryptitis	O
and	O
very	O
focal	O
poorly	O
formed	O
granulomas.	O
No	O
diagnostic	O
changes	O
of	O
chronic	O
colitis	O
seen.	O
MRE:	O
IMPRESSION:	O
1.	O
Left	O
ovarian	O
dermoid	O
cyst.	O
2.	O
Multiloculated	O
ovarian	O
cystic	O
lesions,	O
left	O
greater	O
than	O
right,	O
raise	O
concern	O
for	O
epithelial	O
neoplasms.	O
Recommend	O
pelvic	O
MRI,	O
preferably	O
with	O
contrast	O
(requiring	O
premedication	O
in	O
light	O
of	O
patient	O
allergy).	O
3.	O
Normal	O
MR	O
enterography.	O
4.	O
Left	O
renal	O
RFA,	O
without	O
evidence	O
of	O
recurrence.	O
We	O
recently	O
performed	O
a	O
hydrogen/methane	O
breath	O
test	O
on	O
your	O
patient	O
to	O
evaluate	O
for	O
small	O
intestinal	O
bacterial	O
overgrowth.	O
The	O
procedure	O
was	O
performed	O
using	O
10g	O
of	O
lactulose	O
mixed	O
in	O
8	O
ounces	O
of	O
water.	O
After	O
ingestion	O
of	O
the	O
solution,	O
hydrogen	O
and	O
methane	O
breath	O
samples	O
were	O
then	O
obtained	O
every	O
15	O
minutes	O
for	O
1.5	O
hours.	O
The	O
readings	O
of	O
hydrogen/methane	O
for	O
your	O
patient	O
were	O
as	O
follows:	O
hydrogen/methane	O
Baseline:	O
___	O
ppm	O
15	O
minutes:	O
___	O
ppm	O
30	O
minutes:	O
___	O
ppm	O
45	O
minutes:	O
___	O
ppm	O
60	O
minutes:	O
___	O
ppm	O
75	O
minutes:	O
___	O
ppm	O
90	O
minutes:	O
38/00	O
ppm	O
This	O
study	O
is	O
suggestive	O
of	O
a	O
positive	O
result	O
for	O
bacterial	O
overgrowth	O
based	O
on	O
a	O
rise	O
of	O
equal	O
to	O
or	O
greater	O
than	O
20ppm	O
of	O
hydrogen	O
or	O
methane	O
within	O
90	O
minutes.	O
However,	O
transit	O
time	O
for	O
lactulose	O
through	O
the	O
small	O
bowel	O
to	O
colon	O
is	O
variable	O
and	O
therefore	O
false	O
positive	O
results	O
can	O
not	O
be	O
excluded	O
especially	O
in	O
patients	O
with	O
late	O
rises	O
in	O
hydrogen	O
and/or	O
methane.	O
Brief	O
Hospital	O
Course:	O
___	O
with	O
history	O
of	O
DM2,	O
HTN,	O
HLD,	O
Grave's	O
disease,	O
anemia,	O
obesity	O
presents	O
with	O
nausea,	O
vomiting	O
and	O
diarrhea	O
and	O
found	O
to	O
have	O
a	O
positive	O
bacterial	O
overgrowth	O
breath	O
test.	O
#	O
Bacterial	O
overgrowth:	O
Pt	O
presented	O
with	O
nausea,	O
vomiting,	O
diarrhea.	O
Chronic	O
in	O
nature.	O
Prior	O
evaluation	O
with	O
GI	O
with	O
abnormal	O
pathology	O
although	O
no	O
clear	O
diagnosis.	O
Pt	O
admitted	O
and	O
fluid	O
resuscitated.	O
Pt	O
underwent	O
bacterial	O
overgrowth	O
testing	O
(see	O
above)	O
which	O
was	O
positive.	O
Thus	O
the	O
patient	O
was	O
started	O
on	O
Rifaxamin	O
and	O
discharged	O
with	O
GI	O
follow-up.	O
The	O
patients	O
symptoms	O
had	O
completely	O
resolved	O
on	O
the	O
day	O
of	O
discharge.	O
The	O
patient	O
was	O
also	O
instructed	O
to	O
change	O
from	O
tablet	O
immodium	O
to	O
liquid	O
immodium	O
for	O
better	O
titration.	O
#	O
Acute	O
renal	O
failure	O
on	O
chronic	O
kidney	O
disease	O
stage	O
III:	O
Improved	O
with	O
IVF	O
and	O
in	O
the	O
setting	O
of	O
poor	O
PO	O
intake	O
and	O
diarrhea.	O
Initially	O
all	O
BP	O
meds	O
(ACEi,	O
___,	O
HCTZ)	O
were	O
held.	O
The	O
patient	O
Cr	O
improved	O
back	O
to	O
baseline	O
and	O
her	O
ACEi	O
was	O
restarted	O
in	O
discharge.	O
.	O
#	O
Macular	O
Pruritic	O
Rash:	O
Pt	O
developed	O
pruritis	O
macular	O
rash	O
while	O
in	O
house	O
on	O
arms,	O
legs	O
and	O
back.	O
No	O
clear	O
precipitant.	O
Appeared	O
to	O
blanch.	O
Potentially	O
due	O
to	O
the	O
patients	O
bed	O
sheets.	O
No	O
medication	O
precipitant	O
was	O
identified.	O
Pt	O
was	O
given	O
low	O
dose	O
hydrocortisone	O
cream	O
for	O
treatment.	O
#	O
Anemia:	O
Clinically	O
stable	O
while	O
in	O
house.	O
Unclear	O
etiology.	O
#	O
HTN:	O
Well	O
controlled	O
while	O
in	O
house	O
#	O
DM2:	O
controlled,	O
no	O
complications	O
noted.	O
Held	O
glipizide	O
given	O
renal	O
function.	O
ISS.	O
Restarted	O
on	O
home	O
meds	O
upon	O
discharge.	O
#	O
Grave's	O
disease:	O
presumably	O
post	O
treatment	O
given	O
levothyroxine.	O
Check	O
TSH.	O
#	O
HLD:	O
Continue	O
statin.	O
#	O
s/p	O
rescection	O
of	O
cysts:	O
follow	O
gyn	O
recs	O
contact:	O
___	O
___	O
___	O
___	O
(daughter)	O
TRANSITIONAL	O
ISSUES:	O
-	O
Direct	O
verbal	O
signout	O
provided	O
to	O
the	O
patients	O
PCP	O
on	O
the	O
day	O
of	O
discharge	O
via	O
phone.	O
Medications	O
on	O
Admission:	O
Preadmissions	O
medications	O
listed	O
are	O
incomplete	O
and	O
require	O
futher	O
investigation.	O
Information	O
was	O
obtained	O
from	O
webOMR.	O
1.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO	O
DAILY	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
10	O
mg	O
PO	O
DAILY	O
4.	O
GlipiZIDE	O
2.5	O
mg	O
PO	O
DAILY	O
5.	O
Hydrochlorothiazide	O
25	O
mg	O
PO	O
DAILY	O
6.	O
Lisinopril	O
40	O
mg	O
PO	O
DAILY	O
7.	O
Loratadine	O
*NF*	O
10	O
mg	O
Oral	O
daily	O
8.	O
Simethicone	O
80	O
mg	O
PO	O
TID:PRN	O
gas	O
9.	O
Valsartan	O
160	O
mg	O
PO	O
DAILY	O
10.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
11.	O
Acetaminophen	O
___	O
mg	O
PO	O
Q6H:PRN	O
pain	O
12.	O
OxycoDONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q4H:PRN	O
pain	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
___	O
mg	O
PO	O
Q6H:PRN	O
pain	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
10	O
mg	O
PO	O
DAILY	O
4.	O
Levothyroxine	O
Sodium	O
50	O
mcg	O
PO	O
DAILY	O
5.	O
OxycoDONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q4H:PRN	O
pain	O
6.	O
Simethicone	O
80	O
mg	O
PO	O
TID:PRN	O
gas	O
7.	O
GlipiZIDE	O
2.5	O
mg	O
PO	O
DAILY	O
8.	O
Lisinopril	O
40	O
mg	O
PO	O
DAILY	O
9.	O
Loratadine	O
*NF*	O
10	O
mg	O
Oral	O
daily	O
10.	O
Rifaximin	O
550	O
mg	O
PO	O
TID	O
Duration:	O
10	O
Days	O
RX	O
*rifaximin	O
[Xifaxan]	O
550	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
three	O
times	O
a	O
day	O
Disp	O
#*28	O
Tablet	O
Refills:*0	O
11.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q6H:PRN	O
nausea	O
RX	O
*prochlorperazine	O
maleate	O
10	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
six	O
(6)	O
hours	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
12.	O
Ondansetron	O
8	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
RX	O
*ondansetron	O
8	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
eight	O
(8)	O
hours	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
13.	O
Hydrocortisone	O
Cream	O
1%	O
1	O
Appl	O
TP	O
TID:PRN	O
rash,	O
itching	O
RX	O
*hydrocortisone	O
[cortisone]	O
1	O
%	O
Apply	O
to	O
affected	O
areas	O
___	O
times	O
daily	O
Disp	O
#*1	O
Tube	O
Refills:*0	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis	O
-	O
Acute	O
renal	O
failure	O
-	O
Bacterial	O
Overgowth	O
-	O
Nausea	O
and	O
vomiting	O
-	O
Diarrhea	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
for	O
nausea,	O
vomiting,	O
diarrhea	O
and	O
dehydration.	O
This	O
have	O
been	O
a	O
problem	O
over	O
the	O
last	O
___	O
months.	O
You	O
were	O
evaluated	O
by	O
GI	O
and	O
they	O
recommended	O
rifaxamin	O
for	O
10	O
days.	O
Please	O
keep	O
all	O
of	O
your	O
appointments	O
as	O
listed	O
below.	O
Followup	O
Instructions:	O
___	O

